Poster Abstract Session:
132. Bacteremia and Endocarditis
Friday, October 9, 2015: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

-

Tracks: Adult ID

Presentations:
812
The diagnostic efficacy for combination of nurse-assesed food consumptions and shaking chills in predicting bacteremia at the time of blood culture
Takayuki Komatsu, MD, PhD ; Erika Takahashi, MD ; Kentaro Mishima, MD ; Takeo Toyoda, MD, PhD ; Fumihiro Saitoh, MD ; Manabu Sugita, MD, PhD ; Joel Branch, MD ; Kenji Inoue, MD, PhD
Posters
  • IDSA 2015 (final).pdf (595.6 kB)
  • 814
    Location of Acquisition Impacts the Discharge Status and Length of Stay of Patients with Gram-Positive Bloodstream Infections in Community Hospitals
    Julia Messina, MD, MSc ; Rebekah W. Moehring, MD, MPH ; Vance G. Fowler Jr., MD ; Daniel J. Sexton, MD, FIDSA, FSHEA ; Deverick Anderson, MD, MPH, FIDSA, FSHEA
    Posters
  • IDSA Poster GP BSI_10-6-15 .pdf (356.1 kB)
  • 815
    Combination therapy is superior for treatment of Pseudomonas aeruginosa bloodstream infections (BSI): Analysis of 187 cases
    Sarah Tschudin-Sutter, MD, MSc ; Nicole Fosse, MS ; Maja Weisser, MD ; Reno Frei, MD ; Andreas F. Widmer, MD, MS
    817
    Initial Empiric Carbapenem Use Does Not Improve Mortality in Critically Ill patients with Gram-Negative Bacteremia BUT Increases Multi-Drug Resistant Organisms
    Rui Min Foo, MBBS, MRCP (UK) ; Anupama Vasudevan, BDS, MPH ; Isaac Taoyang Low, BSS ; Amartya Mukhopadhyay, MBBS, MD, MRCP, FRCP, EDIC ; Paul Tambyah, MBBS, M.D., FSHEA
    818
    Risk Factors for and Clinical Outcomes of Multi-Drug Resistant Gram Negative Bacterial Bloodstream Infections: Initial Results from a 12-year Prospective Cohort Study
    Joshua T. Thaden, MD, PhD ; Yanhong Li, MD ; Felicia Ruffin, RN, MSN ; Shelby Reed, PhD ; Vance Fowler Jr, MD
    819
    Prediction of Fluoroquinolone Resistance in Patients with Gram-Negative Bloodstream Infection
    Ansal Shah, MD ; Seejil Dan, MD ; Julie Ann Justo, Pharm D, MS ; P. Brandon Bookstaver, PharmD, FCCP, BCPS (AQ-ID), AAHIVP ; Joseph Kohn, PharmD, BCPS ; Helmut Albrecht, MD ; Majdi Al-Hasan, MD
    Posters
  • Poster Ansal MA revision2.pdf (577.7 kB)
  • 820
    Association between Inappropriate Empirical Antimicrobial Therapy and Hospital Length of Stay in Gram-Negative Bloodstream Infections
    Sarah Cain, BS ; Joseph Kohn, PharmD, BCPS ; P. Brandon Bookstaver, PharmD, FCCP, BCPS (AQ-ID), AAHIVP ; Julie Ann Justo, Pharm D, MS ; Helmut Albrecht, MD ; Majdi Al-Hasan, MD
    Posters
  • Final ID Week poster.pdf (387.5 kB)
  • 821
    Predictors of Mortality from Sepsis among an African Patient Cohort: A Prospective Study from Two Tertiary Healthcare Facilities in Kigali, Rwanda.
    Vincent Sugira, MD, MMed ; Marc Simpao, MD ; Onyema Ogbuagu, MD, FACP ; Timothy Walker, MBBS, FRACP, MPHTM
    Posters
  • Sugira IDSA poster.pdf (529.5 kB)
  • 822
    Evaluation of Empiric Therapy with Third-Generation Cephalosporins for Bloodstream Infections Secondary to Chromosomally-Mediated AmpC-Producing Enterobacteriaceae
    Caroline Derrick, PharmD, BCPS ; Zhiqiang K. Lu, PhD ; P. Brandon Bookstaver, PharmD, FCCP, BCPS (AQ-ID), AAHIVP ; Majdi Al-Hasan, MD ; Christopher M. Bland, PharmD, BCPS ; Bruce Jones, PharmD, BCPS ; Kayla R. Stover, PharmD, BCPS ; S. Travis King, PharmD, BCPS ; Virginia Fleming, PharmD, BCPS ; Trisha N. Branan, PharmD, BCPS ; David Cluck, PharmD ; Brian Odle, PharmD ; V. Paul Dimondi, PharmD, BCPS ; Sandy Estrada, Pharm.D., BCPS (AQ-ID) ; Julie Ann Justo, PharmD, MS, BCPS, AAHIVP
    823
    Clinical features and risk factors for development of breakthrough Gram-negative bacteremia during carbapenem therapy
    Ji-Yong Lee, internal medicine/MD ; Cheol-in Kang, MD ; Jae-Hoon Ko, MD ; Ji-Yeon Lee, MD ; Hye-Ri Seok, MD ; Ga-Eun Park, MD ; Sun Young Cho, MD ; Young Eun Ha, MD ; Doo Ryun Chung, MD PhD ; Kyong Ran Peck, MD ; Jae-Hoon Song, PhD, MD ; Woo Joo Lee, MD
    824
    Clinical and microbiological characteristics of primary bacteremia caused by Klebsiella pneumoniae: a post-hoc analysis of prospective nationwide surveillance
    Kyungmin Huh, MD ; Kyong Ran Peck, MD ; Jinyang Baek, MSc ; Cheol-in Kang, MD ; Doo Ryeon Chung, MD, PhD ; Nam Yong Lee, MD, PhD ; Jae-Hoon Song, MD PhD
    825
    Outcomes in Patients with Carbapenem Resistant Klebsiella pneumoniae (CRKP) Bacteremia
    Aabha Jain, MD ; Samantha Rosenthal, PharmD ; Dong Heun Lee, MD ; Tiffany Bias, PharmD, BCPS, AAHIVP
    827
    Factor associated with mortality in bacteremic cholangitis at a teriary care center in Tokyo, Japan; A 6-year retrospective cohort study
    Yasuaki Tagashira, MD ; Masanori Higuchi, MD ; Mika Kakutani, MD ; Ran Chino, MD ; Akitsu Yoshida, MD ; Hitoshi Honda, MD, PhD
    Posters
  • IDweek No 827. .pdf (308.7 kB)
  • 830
    Risk Factors for viridans group streptococcal bacteremia in neutropenic and non-neutropenic patients at the NIH Clinical Center, 2009-2014: A case-case-control study
    Augusto Dulanto Chiang, M.D. ; Ninet Sinaii, Ph.D., M.P.H. ; Christine D. Spalding, M.S. ; David K. Henderson, M.D. ; Tara N. Palmore, M.D.
    831
    Clinical Characteristics of Group D Streptococcal Bacteremia in a University Hospital in Thailand
    Methee Chayakulkeeree, MD, PhD ; Papatsakorn Nopjaroonsri, MD ; Amornrut Leelaporn, PhD
    Posters
  • GDS Poster_ID week 2015 PDF.pdf (111.1 kB)
  • 832
    Profile of enterococcal bloodstream infection at a tertiary-care hospital in Japan over a 10-year period: Characteristics, outcomes, and predictors for 30-day mortality
    Hiroyuki Suzuki, MD ; Naoto Hosokawa, MD, PhD ; Yoshihito Otsuka, PhD ; Ryota Hase, MD ; Daisuke Suzuki, MD ; Kazuyasu Miyoshi, MD ; Shunsuke Uno, MD ; Akihiro Amma, MD ; Akihiko Shimizu, MD
    834
    Risk Factors Associated with the Development of Linezolid Non-susceptible Vancomycin-Resistant Enterococcus faecium
    Tiffeny Smith, PharmD ; Pranita D. Tamma, MD, MHS ; Kathryn Dzintars, PharmD ; Edina Avdic, MBA, PharmD, BCPS AQ-ID ; Sara Cosgrove, MD, MS, FIDSA, FSHEA
    Posters
  • IDWeek_2015_Ver5.pdf (171.8 kB)
  • 835
    Risk Factors for Treatment Failure and Clinical Outcomes of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children
    Rana F. Hamdy, MD, MPH ; Alice J Hsu, PharmD ; Chris R. Stockmann, MSc ; Jared a. Olson, PharmD ; Matthew Bryan, PhD ; Adam L. Hersh, MD, PhD ; Pranita D. Tamma, MD, MHS ; Jeffrey S. Gerber, MD, PhD
    837
    Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia: A Meta-analysis
    Prakhar Vijayvargiya, MD ; Jessica Porter, MD ; Leonardo Tamariz, MD ; Larry Bush, MD, FACP
    838
    Predictors of Mortality in Cancer Patients with Methicillin-resistant Staphylococcus aureus Bloodstream Infection
    Mohamad Omar Hadied, BS ; Ana C. Bardossy, MD ; Odaliz Abreu-Lanfranco, MD ; Mary Beth Perri, MT ; Samia Arshad, Epidemiologist/MPH ; Marcus Zervos, MD, FIDSA ; George Alangaden, MD, FIDSA
    Posters
  • Hadied_Mohamad_MRSA_Poster.pdf (781.9 kB)
  • 839
    Telavancin in the Treatment of Staphylococcus aureus Bacteremia
    Louis Saravolatz, MD, FIDSA ; Kerry Cleveland, MD, FACP, FIDSA, FSHEA ; Khalid Rikabi, MD ; Ali Hassoun, MD FIDSA FACP ; Leonard B Johnson, MD, FIDSA ; Cedric W. Spak, MD ; Sharon Valenti, CNP ; Susan Szpunar, PhD
    Posters
  • saravolatz tlv 9-29-15.pdf (362.8 kB)
  • 840
    Comparative Effectiveness of Third Generation Cephalosporins versus Penicillinase-Stable Penicillins for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study
    Jennifer Mcdanel, PhD ; Mary-Claire Roghmann, MD, MS, FIDSA, FSHEA ; Eli Perencevich, MD, MS, FIDSA, FSHEA ; Michael Ohl, MD, MSPH ; Michihiko Goto, MD, MSCI ; Daniel Livorsi, MD ; Makoto Jones, MD, MS ; Justin Albertson, MS ; Rajeshwari Nair, MBBS, MPH ; Amy O'shea, PhD ; Marin Schweizer, PhD
    841
    Impact of routine bedside infectious diseases consultation on clinical management and outcome of Staphylococcus aureus bacteraemia in adults
    Rebecca Saunderson, BMedSci MBBS MPhil ; Theodore Gouliouris, BM BCh ; Emma Nickerson, MBBS PhD ; Edward Cartwright, MBBS PhD ; Angela Kidney, BSc ; Sani Aliyu, MBBS FRCP FRCPath ; Nicholas Brown, MBBS FRCPath ; Direk Limmathurotsakul, MD PhD ; Sharon Peacock, PhD FRCP FRCPath ; Estee Torok, PhD FRCP FRCPath
    844
    Elevated vancomycin MIC and presence of deep seated infection in Staphylococcus aureus bacteremia
    Robert Odrobina, MD ; Peter S. Jones, MSLS ; Diana Handrahan, BS ; Jana Coombs, BS ; Bert K. Lopansri, MD ; Michaela Gazdik, PhD ; Edward Stenehjem, MD, MSc
    845
    ¨Staphylococccus aureus Bloodstream Infections in Latin America: Results of a Large Multinational Cohort Study¨
    Carlos Seas, MD, FIDSA ; Coralith Garcia, MD ; Mauro Costa Salles, MD ; Jaime Labarca, MD ; Carlos Alvarez, MD, FIDSA ; Carlos Luna, MD ; Carlos Mejia, MD ; Jeannnete Zurita, MD ; Manuel Guzman-Blanco, MD ; Eduardo Rodriguez-Noriega, MD ; Jinnethe Reyes, PhD ; Cesar Arias, MD, PhD, FIDSA ; Cesar Carcamo, MD, PhD ; Eduardo Gotuzzo, MD, FIDSA
    Posters
  • 845_IDSA_SEAS.pdf (538.5 kB)
  • 846
    Compliance with  Staphylococcus aureus Bacteremia Quality-of-care Guidelines
    Niyati Narsana, MD ; Kristin Mills, MD ; Glenn Wortmann, MD, FIDSA
    Posters
  • 150SAB Graph 84-42.jpg (10.0 MB)
  • 847
    Adherence to quality care indicators targeting Staphylococcus aureus bloodstream infections resulted in a better outcome
    Miki Nagao, M.D., Ph.D. ; Masaki Yamamoto, M.D., Ph.D ; Yasufumi Matsumura, M.D., Ph.D. ; Taro Noguchi, M.D. ; Satoshi Nakano, M.D. ; Karin Kato, M.D. ; Tomoyuki Yunoki, M.D. ; Shunji Takakura, M.D., Ph.D. ; Satoshi Ichiyama, M.D., Ph.D.
    848
    Sulfamethoxazole/trimethoprim vs Fluoroquinolones for the Treatment of Stenotrophomonas maltophilia Bloodstream Infections
    Luke Watson, PharmD ; John Esterly, PharmD ; Michael Postelnick, RPh ; Arturo Aguirre, BS ; Milena Mclaughlin, PharmD, MSc
    849
    Rothia mucilaginosa bacteremia: 8 year review of a single institution experience
    Maheen Abidi, MD ; Nathan Ledeboer, PhD, D(ABMM) ; James Anderson, PhD ; Parameswaran Hari, MD
    Posters
  • Final Rothia ID week.pdf (437.2 kB)
  • 851
    Achromobacter xylosoxidans Bacteremia in Patients with Cancer
    Flor Sánchez-Vargas, MD ; Minh Ho, DO ; Joseph Paruolo, MD ; Kelly Kynaston, DO ; Tyler Stutzman, MPH ; Ana Velez, M.D., F.A.C.P. ; John Greene, MD, FACP, FSHEA
    852
    Clinical Characteristics and Laboratory Examinations of 57 Patients with Mycobacterium Bacteremia
    Sainan Bian, Postgraduate ; Yueqiu Zhang, Graduate ; Lifan Zhang, MD, PhD ; Qiwen Yang, MD ; Peng Wang, Graduate ; Yingchun Xu, MD ; Xiaoqing Liu, Postgraduate
    Posters
  • IDWeek poster-PDF.pdf (483.0 kB)
  • 853
    Current Issues in Patients with Injection Drug Use Associated Infective Endocarditis
    Elana Rosenthal, MD ; Adolf Karchmer, MD, FIDSA ; Roger V Araujo-Castillo, M.D. ; Jesse Theisen-Toupal, MD ; Christopher Rowley, MD/MPH
    Posters
  • IDWeek 2015 - IDUIE Micro.pdf (409.1 kB)
  • 854
    Five-Year Mortality of Native Versus Prosthetic Valve Endocarditis in a Population-Based Cohort
    Abdelghani El Rafei, MD ; Daniel C. Desimone, MD ; James M. Steckelberg, MD, FIDSA ; Muhammad R. Sohail, MD, FIDSA ; Walter R. Wilson, MD, FIDSA ; Larry M. Baddour, MD, FIDSA
    Posters
  • IE mortality results.pdf (186.9 kB)
  • 855
    Characteristics of 96 Healthcare-associated Infective Endocarditis Patients
    Fabrice Camou, MD ; Gaetane Wirth, MD ; Carine Greib, MD ; Marina Dijos, MD ; Sunthareth Yeim, MD ; Pierre Poustis, MD ; Olivia Peuchant, MD, PhD ; Nahema Issa, MD
    Posters
  • POSTER ID-WEEK 2015.pdf (573.0 kB)
  • 856
    Polymicrobial Infective Endocarditis
    Shailee Shah, MD ; Nabin Shrestha, MD, MPH, FIDSA, FSHEA ; Steven Gordon, MD, FIDSA, FSHEA
    Posters
  • shrestha layout 102801.pdf (218.5 kB)
  • 857
    Endocarditis Caused by MRSA with Reduced Susceptibility to Vancomycin and Daptomycin and Resistance to Ceftaroline: Treatment Approach and Evidence of Patient to Patient Transmission
    Masayuki Nigo, MD ; L. Paola Carvajal, BSc ; Truc Tran, PhamD ; Rafael Rios, MSc ; Jose Munita, MD ; Diana Panesso, PhD ; Audrey Wanger, PhD ; Lorena Diaz, PhD ; Cesar Arias, MD, PhD, FIDSA
    858
    Beta Hemolytic Streptococcus Infective Endocarditis: Factors Associated with Early Mortality
    Abdelghani El Rafei, MD ; Daniel Desimone, MD ; Christopher Desimone, MD, PHD ; Brian Lahr, MS ; James Steckelberg, MD, FIDSA ; Muhammad R. Sohail, MD, FIDSA ; Walter R. Wilson, MD, FIDSA ; Larry Baddour, MD, FIDSA
    Posters
  • BHS IE.pdf (276.3 kB)
  • 859
    Infective Endocarditis due to Bartonella spp and Coxiella Burnetti : Comparative Analysis from Prevalence to Management
    Sahar Ben Kahla, MD ; Leila Abid, MD ; Makram Koubaa, MD ; Abir Znazen, MD ; Dorra Abid, MD ; Adnane Hammami, MD ; Mounir Ben Jemaa, MD ; Samir Kammoun, MD
    Posters
  • P 859.pdf (187.8 kB)
  • 860
    Predictors of Mortality in End Stage Renal Disease Patients with Infective Endocarditis
    Rachel Powell, MD ; James P. Steinberg, MD, FIDSA, FSHEA ; Jesse T. Jacob, MD
    861
    Aminoglycosides for Surgically Treated Enterococcal Endocarditis
    Jona Banzon, MD ; Syed Hussain, MD ; Steven Gordon, MD, FIDSA, FSHEA ; Gosta Pettersson, MD, PhD ; Robert Butler, MS ; Nabin Shrestha, MD, MPH, FIDSA, FSHEA
    Posters
  • idsa_poster.png (3.7 MB)
  • 862
    Addictions Interventions in Patients Admitted with Injection Drug Use Complicated by Infective Endocarditis
    Elana Rosenthal, MD ; Adolf Karchmer, MD, FIDSA ; Jesse Theisen-Toupal, MD ; Roger V Araujo-Castillo, M.D. ; Christopher Rowley, MD/MPH

    CME Credits:

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.